期刊文献+

19A型肺炎链球菌多糖结合物中游离多糖含量测定方法的建立 被引量:2

Method development for determination of free polysaccharide content in Streptococcus pneumoniae type 19A polysaccharide conjugate
原文传递
导出
摘要 目的建立19A型肺炎链球菌多糖(Streptococcus pneumoniae type 19A polysaccharide,19APS)结合物中游离PS含量的测定方法。方法在一定条件下分别用1、3和5g/L脱氧胆酸钠(sodiumdeoxycholate,IX)C)溶液(pH7.3)沉淀不同浓度的破伤风类毒素(tetanustoxoid,1vr),确定不同浓度DOC沉淀载体蛋白1vr的浓度范围。以1g/LDOC分离结合19APS(19APS-TT)和游离19APS,测定上清液中的游离PS含量,并验证该DOC沉淀法的准确度和精密度。结果分别以1和3g/LDOC沉淀19APS-TT时,TT浓度最好分别控制在〈150和〈200μg/ml。该DOC沉淀法的准确度和精密度均良好,加标PS回收率为94.0%~107.2%,相对标准偏差均〈4%。结论成功建立了19APS-TT中游离PS含量的测定方法。 Objective To develop a method for determinanon oi lree polysaccnanae content in Streptococcus pneumoniae type 19A polysaccharide (19APS) conjugate. Methods Tetanus toxoid (TT) solutions of different concentrations were precipitated using 1, 3 and 5 g/L sodium deoxycholate (DOC) (pH7. 3), respectively, under certain conditions. The concentration ranges of carrier protein TT precipitated with different concentrations of DOC were determined. The conjugated 19APS (19APS-TT) and free 19APS were separated using 1 g/L DOC, and free PS contents in supernatant were detected. The accuracy and precision of the DOC precipitation method were validated. Results When 19APS-TT was precipitated using 1 and 3 g/L DOC, the TT concentrations should he controlled in 〈 150 and 〈200μg/ml, respectively. The DOC precipitation method had good accuracy and precision. The adding recovery rates of PS were 94. 0%-107. 2%, and the relative standard deviations of the DOC precipitation method were all 〈 4%. Conclusion The method for determination of free polysaccharide content in 19APS-TT is developed successfully.
出处 《国际生物制品学杂志》 CAS 2017年第4期157-157,158-160,共4页 International Journal of Biologicals
关键词 链球菌 肺炎 多糖类 细菌 化学沉淀 Streptococcus pneumoniae Polysaccharides, bacterial Chemical precipitation
  • 相关文献

参考文献3

二级参考文献17

  • 1朱为,毕慧,黄帼英,金铭.A群脑膜炎球菌多糖结合疫苗的稳定性[J].中国生物制品学杂志,2004,17(6):408-409. 被引量:2
  • 2吴凯,代泽友,马波,周燕美,吴绍学,樊会兰,黄镇.改进的蒽酮法检测肺炎链球菌荚膜多糖结合物中多糖浓度[J].中国生物制品学杂志,2007,20(7):536-538. 被引量:8
  • 3国家食品药品监督管理局.结合疫苗质量控制和临床研究技术指导原则.2005-10-14.
  • 4Li, N.; Gu, Z. Y. Foreign Medical Sciences, 1984, 5:263[李宁, 顾倬云. 国外医学( Guowai Yixue), 1984, 5: 263]
  • 5Small, D. M.; Bougles, M.; Dernichiam, D. G. Nature, 1966,211:816
  • 6Kurtin, W.; Wright, L. K.; Chosed, R. J. Abstracts of Papers of the American Chemical Society, 2000, 21 (9): 611
  • 7Bechi, P.; Cianchi, F.; Mazzanti, R.; Fantappie, O.; Fiorillo, C.;Nassi, P. Diseases of the Esophagus, 2000,13(1): 51
  • 8de Sanctis, S. C.; D'Archivio, A. A.; Galantini, L. Journal of the Chemical Society-Perkin Transactions 2, 2000, (2):403
  • 9Dawes, L. G.; Greiner, M. A.; Joehl, R. J. Journal of Surgical Research, 1999, 81 (1): 21
  • 10Zhang, L.; Yang, Z. L.; Soloway, R. D.; Weng, S. F.; Wu, J. G.Gastroenterology, 2000, 118(4): 310

共引文献14

同被引文献7

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部